What GLP-1 treatment costs with cash-pay telehealth

Cash-pay means the number on the page is the number

Many U.S. adults pay for incretin therapy without running it through an obesity-drug insurance benefit. Cash-pay telehealth programs bundle clinician time, medication, supplies, and shipping into a monthly or prepaid rate so you are not reconciling five invoices. That model is what Beema publishes. It is not a claim that insurance never covers GLP-1s somewhere else, and this page will not do insurance math.

This article is educational. The interactive plan selector on compounded semaglutide and compounded tirzepatide is the live price UI. If those pages and this article ever disagree, trust the lockup.

Compounded semaglutide cash-pay rates (Beema)

Compounded semaglutide is $199/month billed monthly. On a 3-month plan, one-time code sema-off100 brings your first month to $99, then $199/mo for months 2 and 3 ($497 total). Longer plans are $165.67/mo on 6 months (save $200) or $155.75/mo annually (save $519). Promo code sema-off100 can also take an additional $100 off 6- and 12-month plans at checkout; it can't be combined with a 1-month purchase and can only be redeemed once per patient. Confirm the lockup on /semaglutide. Compounded semaglutide is not FDA-approved and is considered only when legally available and clinically appropriate. Prescribing is never guaranteed.

Compounded tirzepatide cash-pay rates (Beema)

Compounded tirzepatide pricing: 3-month starter pack - brand-new patients beginning tirzepatide can get doses 1 → 2 → 3 (2.5mg → 5mg → 7.5mg) for $597 over 3 months ($199/month); typically one-time. To be presented this starter price, mark that you are new to GLP-1 when asked during intake. After that, maintenance is $297/mo monthly, $263.67/mo on a 3-month plan (save $100), $249.5/mo on a 6-month plan (save $285), or $232.33/mo annually (save $776). Promo code Tirz100 is a one-time-use code for an additional $100 off 3-, 6-, and 12-month plans at checkout; it can't be combined with a 1-month purchase or the starter pack, and can only be redeemed once per patient. The starter pack and the $100-off promo code can't be used together. Confirm the lockup on /tirzepatide. Compounded tirzepatide is not FDA-approved and is considered only when legally available and clinically appropriate. Prescribing is never guaranteed.

What these prices are not

They are not a medical-necessity argument. Lower cash price does not prove a compounded product is legally interchangeable with a brand. They are not Ozempic or Wegovy list prices. They are not a promise you will be prescribed anything. They are not research-peptide catalog prices, which you should not pay anyway.

How to compare cash-pay programs without a brand table

Ask what is included. Ask whether refill shipping is extra. Ask whether labs are extra. Ask whether the quoted rate assumes a coupon that expires. Ask who the prescriber is. Beema's dual-medication teaser on marketing pages is Semaglutide from $99 first month on a 3-month plan · Tirzepatide starter from $199/mo · one-time $100 off codes, with full math on the medication pages. Other clinics will quote other bundles. Compare bundles, not a screenshot of a manufacturer's list price.

Where to go next

For the program shape, read the GLP-1 weight-loss program article. For lawful online access, read online GLP-1. For molecule evidence, read semaglutide for weight loss and tirzepatide online. When you want to start, use the program overview, compounded semaglutide, or compounded tirzepatide. A licensed clinician reviews each intake and decides whether any medication is appropriate. Completing an online intake does not guarantee a prescription.

Frequently asked questions

Sources

1. [1] Beema Health live cash-pay rates are maintained in medication pricing on /semaglutide and /tirzepatide (provider care, medication, supplies, expedited shipping; no membership fee).
2. [2] NIDDK. Prescription obesity medications: cost and coverage vary; cash-pay programs exist separately from insurance benefit design.
3. [3] U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss.
4. [4] Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021. Efficacy evidence is not a price list.